HMR Expands Vertex Deal; Gains U.S. Rights To Arthritis Compound
Executive Summary
Hoechst Marion Roussel is expanding its development deal with Vertex for the anti-inflammatory agent HMR 3480/VX-740 to include U.S. marketing rights, the firms said Sept. 1.